Author

Marzena Dyba

Frederick National Laboratory for Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Sergey G. TarasoviD· 2 shared Baktiar O. KarimiD· 1 shared Bao Quoc TraniD· 1 shared Caroline FromontiD· 1 shared Charles D. SchwietersiD· 1 shared Christine N. Evans· 1 shared Dominique T. FergusoniD· 1 shared Donna O. ButcheriD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Sergey G. TarasovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Angulin-1/LSR inhibition transiently disrupts the blood-tumor barrier to enhance doxil permeability and impair malignant glioma progression

Dominique T. Ferguson, Minhye Kwak, Sanghee Lim, Melissa Cesaire, Jatia Mills, Mahalia Dalmage, Jane Jones, Sergey G. Tarasov, Marzena Dyba, Robert W. Robey, Yanbo Yang, Shae K. Simpson, Baktiar O. Karim, Donna O. Butcher, Robyn D. Gartrell, , Sadhana Jackson

The paper investigates how Angubindin-1 disrupts the blood-tumor barrier by targeting Angulin-1/LSR, enhancing drug permeability and reducing glioma progression.

bioRxiv · Jul 31, 2025 · PreprintCell Biology

Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma

Xiuxiu Lu, Venkata R. Sabbasani, Vasty Osei Amponsa, Christine N. Evans, Julianna C. King, Sergey G. Tarasov, Marzena Dyba, Sudipto Das, King C. Chan, Charles D. Schwieters, Sulbha Choudhari, Caroline Fromont, Yongmei Zhao, Bao Quoc Tran, Xiang Chen, , Kylie J. Walters

The paper identifies a chemical scaffold targeting hRpn13, revealing a DEUBAD-lacking isoform upregulated in multiple myeloma and demonstrating its potential as a therapeutic target.

Nature Communications · Dec 16, 2021Peer-reviewedMolecular Biology